The DNB//Back Bay Partnership for healthcare growth is pleased to present the best publicly-traded Nordic biopharma and medical technology companies focused in areas with high patient needs, including cancer, GI, metabolism, neurology, rare diseases, transplantation, vaccines, and others. In addition, come hear from our expert panel on the current state of the Global Healthcare Capital Markets and where we are headed.

• Presentations by Nordic public companies
• Expert panel discussion: Global Healthcare Capital Markets - Where are we and where are we headed?